TEVA Pharmaceutical Industries Ltd

TEVA
As of the close on Sep 25, 2026
Price
$39.19
Market cap
—
The company filed earlier annual reports as a foreign issuer, and its US listing is not confirmed to be one ordinary share
P/E (diluted TTM)
—
The company filed earlier annual reports as a foreign issuer, and its US listing is not confirmed to be one ordinary share
EPS (TTM)
—
The company filed earlier annual reports as a foreign issuer, and its US listing is not confirmed to be one ordinary share
Dividend yield
—
The company filed earlier annual reports as a foreign issuer, and its US listing is not confirmed to be one ordinary share

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How TEVA Pharmaceutical Industries Ltd Makes Money

Follow each dollar of revenue through to what shareholders keep.

From revenue to net income

Pick a year or quarter. Each band's width is its dollar amount.

Source: TEVA Pharmaceutical Industries Ltd — 10-Q filed Jul 29, 2026

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 18 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 22, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Reported 13F positions

Each row shows what a filer reported for one date, not a current position. The link opens that filing.

Filer Report date Shares Value Filing
Cinctive Capital Management LP 2026-03-31 122,133 $3.68M SEC filing
FIL Ltd 2026-03-31 3,694,634 $111M SEC filing
Vanguard Personalized Indexing Management, LLC 2026-03-31 33,705 $1.02M SEC filing
Havemeyer Place LP 2026-03-31 56,695 $1.71M SEC filing
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 2026-03-31 57,244 $1.72M SEC filing
Dai-ichi Life Insurance Company, Ltd 2026-03-31 39,855 $1.2M SEC filing
Mitsubishi UFJ Asset Management Co., Ltd. 2026-03-31 1,229,175 $37M SEC filing
MetLife Investment Management, LLC 2026-03-31 108,925 $3.28M SEC filing
First Command Advisory Services, Inc. 2026-03-31 324 $9.76K SEC filing
UMB Bank, n.a. 2026-03-31 3,726 $112K SEC filing
Summit Trail Advisors, LLC 2026-03-31 13,530 $408K SEC filing
Zurcher Kantonalbank (Zurich Cantonalbank) 2026-03-31 595,032 $17.9M SEC filing
FORA Capital, LLC 2026-03-31 49,372 $1.49M SEC filing
Bayforest Capital Ltd 2026-03-31 1,455 $43.8K SEC filing
IFM Investors Pty Ltd 2026-03-31 244,364 $7.36M SEC filing
OKABENA INVESTMENT SERVICES INC 2026-03-31 23,518 $708K SEC filing
CHANNEL WEALTH LLC 2026-03-31 6,915 $208K SEC filing
Generali Investments CEE, investicni spolecnost, a.s. 2026-03-31 20,400 $614K SEC filing
Aspect Partners, LLC 2026-03-31 50 $1.51K SEC filing
JPMORGAN CHASE & CO 2026-03-31 6,762,744 $192M SEC filing

120 filers have only one report here.

Unusually large insider trades

Each trade is compared with the other insider trades of the same kind in the same security among TEVA Pharmaceutical Industries Ltd's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.

  • 2026-03-03 · Francis Richard D: Larger than all 54 other insider sales of Ordinary Shares on file. SEC filing
  • 2026-02-26 · Kalif Eliyahu Sharon: Larger than 53 of the 54 other insider sales of Ordinary Shares on file. SEC filing
  • 2026-02-15 · Francis Richard D: Larger than 51 of the 54 other insider sales of Ordinary Shares on file. SEC filing
  • 2026-02-15 · Francis Richard D: Larger than 49 of the 54 other insider sales of Ordinary Shares on file. SEC filing
  • 2025-11-06 · MIGNONE ROBERTO: Larger than 50 of the 54 other insider sales of Ordinary Shares on file. SEC filing
  • 2025-05-08 · Sabag Mark: Larger than 52 of the 54 other insider sales of Ordinary Shares on file. SEC filing

Purchases & sales (open market or private)

SecurityCodePriceFiling
2026-06-18Shields Matthew · EVP, Global OperationsOrdinary SharesS — Open market or private sale−9,98932.19SEC filing
2026-06-11Kalif Eliyahu Sharon · EVP, Chief Financial OfficerOrdinary SharesS — Open market or private sale−106,56334.10SEC filing
2026-06-05Francis Richard D · President and CEOOrdinary SharesS — Open market or private sale−6,15334.35SEC filing
2026-06-03Shields Matthew · EVP, Global OperationsOrdinary SharesS — Open market or private sale−16,19532.87SEC filing
2026-05-14Lippman Evan · EVP, Business DevelopmentOrdinary SharesS — Open market or private sale−35,91235.58SEC filing
2026-05-14Lippman Evan · EVP, Business DevelopmentOrdinary SharesS — Open market or private sale−5,74635.58SEC filing
2026-05-14Kalif Eliyahu Sharon · EVP, Chief Financial OfficerOrdinary SharesS — Open market or private sale−153,25135.61SEC filing
2026-05-06Weiss Amir · Chief Accounting OfficerOrdinary SharesS — Open market or private sale−10,67936.00SEC filing

Showing 8 of 11 rows

Grants, exercises, tax & gifts

SecurityCodeFiling
2026-06-05Francis Richard D · President and CEOOrdinary SharesM — Exercise or conversion of derivative security+13,043SEC filing
2026-06-05MIGNONE ROBERTO · DirectorRestricted Share UnitsM — Exercise or conversion of derivative security−14,492SEC filing
2026-06-05Crane Rosemary A · DirectorRestricted Share UnitsM — Exercise or conversion of derivative security−14,492SEC filing
2026-06-05LIEBERMAN GERALD M · DirectorOrdinary SharesM — Exercise or conversion of derivative security+14,492SEC filing
2026-06-05Nisen Perry · DirectorOrdinary SharesM — Exercise or conversion of derivative security+14,492SEC filing
2026-06-05Lichtenstein Chen · DirectorRestricted Share UnitsM — Exercise or conversion of derivative security−14,492SEC filing
2026-06-05Francis Richard D · President and CEORestricted Share UnitsM — Exercise or conversion of derivative security−13,043SEC filing
2026-06-05Elstein Amir · DirectorOrdinary SharesM — Exercise or conversion of derivative security+14,492SEC filing

Showing 8 of 20 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.